Learning Objectives:
•Recognize unmet needs in the current clinical landscape of NSCLC treatments and biomarkers
•Understand the utility of stable isotope tracing to measure tumor metabolism
•Understand the therapeutic potential of targeting metabolic adaptations in NSCLC
Session date:
11/18/2024 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. Robert Cameron